Latest News
Instem Awarded EMA Research Grant
Instem Secures Portion of €2.5m Grant as Member of Research Consortium Investigating the Mutagenicity of N-nitrosamines
PHILADELPHIA, PA – (BUSINESS WIRE) – May 10, 2022 - Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has been awarded a European Medicines Agency (EMA) grant as part of an EMA-funded research project to better understand the mutagenicity of N-nitrosamines.
Instem Expands In Silico Toxicology Service To Meet Growing Demand
November 22, 2021 - Newly Added Services to Support Latest Regulatory Guidance and Growing Demand for Alternative Testing Methods
Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently
September 1, 2021 - Acquisition of PDS Life Sciences Consolidates Non-Clinical Market; Further Extends Instem’s Leadership in Study Management and Regulatory SEND Submission Support
Instem to Release Next Edition of its Leading Computational Toxicology Software Suite
July 29, 2021 - Powerful New In Silico Models and First-to-Market Software Capabilities to Deliver Further Efficiencies and Increased Regulatory Compliance
Instem Acquires Market Leader d-wise to Further Accelerate Life Science Development
March 22, 2021 - Instem’s Acquisition of Leading Clinical Trial Technology and Consulting Provider d-wise Represents Substantial Advancement of its Mission
Events
ICAW & EEMGS meeting
May 23 - 26, 2022
Crowne Plaza, Maastricht, The Netherlands
Informa Clinical Data Disclosure Meeting (CDD)
June 13 - 14, 2022
Hybrid Event - Hyatt Regency Coral Gables, Miami
STP 41st Annual Meeting
June 19 - 23, 2022
Austin Marriott Downtown, Austin, Texas, Booth #103
Poster:
'Communicate the future proposed Microscopic domain additions or changes to the SEND Implementation Guide'
Dan Potenta, SEND Product Specialist